NEUPATH HEALTH INC (NPTH.CA) Stock Fundamental Analysis
TSX-V:NPTH - CA64133P1009 - Common Stock
0.31 CAD
-0.01 (-1.59%)
We assign a fundamental rating of 3 out of 10 to NPTH. NPTH was compared to 15 industry peers in the Health Care Providers & Services industry. The financial health of NPTH is average, but there are quite some concerns on its profitability. NPTH has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
NPTH had negative earnings in the past year.
In the past year NPTH had a positive cash flow from operations.
NPTH had negative earnings in each of the past 5 years.
NPTH had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of NPTH (-1.83%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -3.75%, NPTH is in line with its industry, outperforming 53.33% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.40%, NPTH is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.83% | ||
| ROE | -3.75% | ||
| ROIC | 4.4% |
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NPTH's Operating Margin of 2.49% is in line compared to the rest of the industry. NPTH outperforms 53.33% of its industry peers.
With a Gross Margin value of 19.09%, NPTH is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of NPTH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.49% | ||
| PM (TTM) | N/A | ||
| GM | 19.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NPTH is destroying value.
The number of shares outstanding for NPTH remains at a similar level compared to 1 year ago.
NPTH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NPTH has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.67, we must say that NPTH is in the distress zone and has some risk of bankruptcy.
NPTH has a Altman-Z score of 1.67. This is in the better half of the industry: NPTH outperforms 66.67% of its industry peers.
The Debt to FCF ratio of NPTH is 6.29, which is on the high side as it means it would take NPTH, 6.29 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 6.29, NPTH is doing good in the industry, outperforming 73.33% of the companies in the same industry.
NPTH has a Debt/Equity ratio of 0.50. This is a neutral value indicating NPTH is somewhat dependend on debt financing.
NPTH has a Debt to Equity ratio of 0.50. This is in the better half of the industry: NPTH outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 6.29 | ||
| Altman-Z | 1.67 |
ROIC/WACC0.66
WACC6.7%
2.3 Liquidity
A Current Ratio of 1.20 indicates that NPTH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.20, NPTH belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
NPTH has a Quick Ratio of 1.20. This is a normal value and indicates that NPTH is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.20, NPTH belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
The earnings per share for NPTH have decreased strongly by -928.57% in the last year.
Looking at the last year, NPTH shows a quite strong growth in Revenue. The Revenue has grown by 14.65% in the last year.
The Revenue has been growing slightly by 7.96% on average over the past years.
EPS 1Y (TTM)-928.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.38%
Revenue 1Y (TTM)14.65%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%25.16%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y178.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
NPTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
NPTH is valuated quite expensively with a Price/Forward Earnings ratio of 30.69.
66.67% of the companies in the same industry are more expensive than NPTH, based on the Price/Forward Earnings ratio.
NPTH's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.54.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 30.69 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NPTH indicates a rather cheap valuation: NPTH is cheaper than 93.33% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, NPTH is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.95 | ||
| EV/EBITDA | 6.09 |
4.3 Compensation for Growth
NPTH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NPTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:NPTH (9/10/2025, 7:00:00 PM)
0.31
-0.01 (-1.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners24.78%
Inst Owner ChangeN/A
Ins Owners1.82%
Ins Owner ChangeN/A
Market Cap17.51M
Analysts80
Price Target0.51 (64.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)1.03%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 30.69 | ||
| P/S | 0.22 | ||
| P/FCF | 8.95 | ||
| P/OCF | 6.72 | ||
| P/B | 0.82 | ||
| P/tB | 257.44 | ||
| EV/EBITDA | 6.09 |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.01
Fwd EY3.26%
FCF(TTM)0.03
FCFY11.17%
OCF(TTM)0.05
OCFY14.88%
SpS1.41
BVpS0.38
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.83% | ||
| ROE | -3.75% | ||
| ROCE | 6.11% | ||
| ROIC | 4.4% | ||
| ROICexc | 5% | ||
| ROICexgc | 19.84% | ||
| OM | 2.49% | ||
| PM (TTM) | N/A | ||
| GM | 19.09% | ||
| FCFM | 2.46% |
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
F-Score5
Asset Turnover1.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 6.29 | ||
| Debt/EBITDA | 2.49 | ||
| Cap/Depr | 27.81% | ||
| Cap/Sales | 0.82% | ||
| Interest Coverage | 6.88 | ||
| Cash Conversion | 60.43% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 1.67 |
F-Score5
WACC6.7%
ROIC/WACC0.66
Cap/Depr(3y)39.19%
Cap/Depr(5y)26.48%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-928.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.38%
EPS Next Y178.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.65%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%25.16%
Revenue Next Year8.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y97.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.08%
FCF growth 3Y3.23%
FCF growth 5YN/A
OCF growth 1Y0%
OCF growth 3Y10.75%
OCF growth 5YN/A